Compound Detail
CHEMBL4798141
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3cn[nH]c3n2)c(OC(C)C)cc1C1CCN(C)CC1
Basic Information
| ChEMBL ID | CHEMBL4798141 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CWXBESRGEPLREF-UHFFFAOYSA-N |
5
Targets
5
Activities
1
Assay Types
3
PK Parameters
8
Publications
0
Known Names
Molecular Properties
577.8
MW (Da)
5.93
ALogP
9
HBA
3
HBD
125.1
PSA (Ų)
0.22
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) CHEMBL2111387 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| Insulin receptor CHEMBL1981 | IC50 | 6.15 | 6.15 | 703.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.48 | 5.48 | 3300.0 | 1 |
| BaF3 CHEMBL614524 | IC50 | 5.29 | 5.29 | 5120.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 37.0 | mL.min-1.g-1 | Mus musculus |
| CL | 30.0 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 32.0 | mL.min-1.g-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) | IC50 | = | 13.0 | nM | 7.89 | Inhibition of NMP-ALK (unknown origin) expressed in mouse BaF3 cells assessed as... | 26750252 |
| Insulin receptor | IC50 | = | 703.0 | nM | 6.15 | Inhibition of Tel fused InsR (unknown origin) expressed in mouse BaF3 cells asse... | 26750252 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 1000.0 | nM | 6.0 | Inhibition of human ERG by dofetilide binding assay | 26750252 |
| Cytochrome P450 3A4 | IC50 | = | 3300.0 | nM | 5.48 | Inhibition of CYP3A4 (unknown origin) using midazolam as substrate | 26750252 |
| BaF3 | IC50 | = | 5120.0 | nM | 5.29 | Antiproliferative activity against wild type mouse BaF3 cells assessed as reduct... | 26750252 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26750252 | 10.1016/j.bmcl.2015.11.049 | ADMET | 6 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) | 1 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | Insulin receptor | 1 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | BaF3 | 1 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | Cytochrome P450 3A4 | 1 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | No relevant target | 1 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 26750252 | 10.1016/j.bmcl.2015.11.049 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine